EP2956477

BIOGEN MA INC.
Application Number
EP14751254A
Filing Date
Feb 14, 2014
Status
Patent Maintained As Amended
Dec 22, 2023
Grant Date
Jan 24, 2024
External Links
Slate, Register

Biblio Summary

The patent EP2956477B2 was granted on Jan 24, 2024 by Biogen Ma Inc. The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

J A KEMP LLPAug 17, 2021ADMISSIBLE

The table below shows the patents of Biogen Ma Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2645106Methods And Products For Evaluating An Immune Response To A Therapeutic AgentOct 2, 20241
EP3036320Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process ParametersApr 3, 20241
EP3999643Methods Of Treating Or Preventing Spinal Muscular AtrophyNov 22, 20235